Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | LFMD LifeMD, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.23 +0.2% | $15.82 +5.0% |
| StockIQ Score | 50C- Moderate Risk: High | 38F Weak Risk: Medium |
| Technical | 30F | 21F |
| Fundamental | 63C+ | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 55C | 38F |
| News | 32F | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
LifeMD shows stronger growth potential with a growth score of 68 compared to Ascentage Pharma’s 50. Its fundamental score of 54 also outperforms Ascentage’s 35, indicating better underlying health. However, Ascentage’s valuation score of 38 is slightly more favorable than LifeMD’s 55. Overall, LifeMD leads in growth and fundamentals.
